To explore whether a larger amount of anti-LPS antibodies than a vaccine elicits can prevent disease, we boosted IgA and/or IgG antibody numbers prior to infection via initial conditions and tracked the number of Shigella bacteria in the epithelium 45 days later. The gene discussed is CD79A; the disease is infection.